Carlos Pagnano

Finance Director, Partner and Emerging Markets at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Carlos Pagnano's Colleagues at Alnylam Pharmaceuticals
Bibash Bajgai

Crew at Alnylam Pharmaceuticals

Contact Bibash Bajgai

Mayumi Gonome

Human Resources Director

Contact Mayumi Gonome

Virginia Lepri

Insights Lead International Markets @ Global Commercial

Contact Virginia Lepri

Patrick Berreby

Vice President Supply Chain

Contact Patrick Berreby

Deepa Elango

Senior EHS Specialist at Alnylam Pharmaceuticals

Contact Deepa Elango

Nagi Harada

Manager, Regulatory Operations

Contact Nagi Harada

View All Carlos Pagnano's Colleagues
Carlos Pagnano's Contact Details
HQ
(617) 551-8200
Location
São Paulo,State of São Paulo,Brazil
Company
Alnylam Pharmaceuticals
Carlos Pagnano's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Carlos Pagnano
Carlos Pagnano currently works for Alnylam Pharmaceuticals.
Carlos Pagnano's role at Alnylam Pharmaceuticals is Finance Director, Partner and Emerging Markets.
Carlos Pagnano's email address is ***@alnylam.com. To view Carlos Pagnano's full email address, please signup to ConnectPlex.
Carlos Pagnano works in the SaaS industry.
Carlos Pagnano's colleagues at Alnylam Pharmaceuticals are Jessika Taurino, Bibash Bajgai, Mayumi Gonome, Virginia Lepri, Patrick Berreby, Deepa Elango, Nagi Harada and others.
Carlos Pagnano's phone number is (617) 551-8200
See more information about Carlos Pagnano